Real-Time Pathogen-Host Interactome Prediction
SBIR Opportunity Analysis
DARPA, within the Department of Defense, is seeking a Direct to Phase II SBIR capability for real-time pathogen-host interactome prediction to rapidly characterize biological threats from pathogen protein sequence alone. The work is to develop and validate an operationally deployable pipeline that predicts host-pathogen protein interactions, provides functional annotation, generates ranked mechanistic hypotheses, and produces full characterization reports. The system must generalize to unseen pathogens, cover viral, bacterial, and parasitic classes, be benchmarked against established interaction databases, and complete core predictions within 15 minutes and full reports within one hour on standard computing hardware. Phase II calls for scaling and validation, experimental confirmation of novel predicted interactions, and transition-ready software delivery with drug repurposing demonstration. The opportunity was released June 3, 2026, opens June 24, 2026, and closes with applications due July 22, 2026 at 4:00 PM UTC.